http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2006080463-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2006-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-WO2006080463-A1 |
| titleOfInvention | Cancer therapeutic agent and recurrence preventive agent using vitamin K hydroquinone derivative |
| abstract | Provided is an excellent cancer therapeutic agent, cancer recurrence preventive agent or action enhancer containing at least one of carboxylic acid esters of vitamin K hydroquinone represented by the following general formula (I) or a salt thereof. Wherein R 1 and R 2 are each a hydrogen atom, or an amino acid, an N-acyl amino acid, an N-alkyl amino acid, an N, N-dialkyl amino acid, a pyridinecarboxylic acid, and their hydrohalides and alkylsulfonates. Or a carboxylic acid residue having a nitrogen substituent selected from residues of sugar salts, or a dicarboxylic acid residue selected from residues of dicarboxylic acids and alkali metal salts thereof, R 1 , At least one of R 2 is a carboxylic acid residue having a nitrogen substituent or a dicarboxylic acid residue. R 3 represents a hydrogen atom or a group represented by general formula (II) or general formula (III). n means an integer of 1 to 14. ) |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10159687-B2 |
| priorityDate | 2005-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 114.